Advanced Biomed INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Advanced Biomed Inc. reported significant net losses and negative operating cash flows for fiscal year 2025, alongside a Nasdaq minimum bid price non-compliance notice, while advancing product development and global expansion plans.